Abstract || Annals of Clinical Case Reports

Major Scope

Cardiovascular Case Reports
Oncology Case Reports
Surgical Case Reports
Gastroenterological Case Reports
Neurological Case Reports
Dermatological Case Reports
Respiratory Case Reports
Obstetrics/Gynecology Case Reports
Nephrology Case Reports
Immunology Case Reports
Paediatric Case Reports
Orthopedics Case Reports
Dental Case Reports

Abstract

Citation: Ann Clin Case Rep. 2017;2(1):1396.DOI: 10.25107/2474-1655.1396

A Case of Bupropion-Induced Toxic Epidermal Necrolysis (TEN)

Temiz Selami Aykut, Dursun Recep, Daye Munise, Ataseven Arzu and Özer İlkay

Department of Dermatology, Meram Faculty of Medicine, Necmettin Erbakan University Konya, Turkey

^*Correspondance to: Ataseven Arzu

PDF Full Text Case Report | Open Access

Abstract:

Toxic Epidermal Necrolysis (TEN), which has high mortality, is an acute mucocutaneous disease with bullous lesions in the skin, eyes and mucosae. It often develops due to medications. Bupropion is an antidepressant that blocks neural dopamine and the noradrenaline reuptake. Its slow-release form is used in smoking cessation treatments. In the literature, Bupropion-induced side effects have been reported such as urticaria angioedema, erythema multiforme, and acute generalized eczematous pustulosis. We found it appropriate to present our case of Bupropion-induced toxic epidermal necrolysis, which has not yet been presented in the literature.

Keywords:

Toxic epidermal necrolysis; Urticarial; Bupropion; Immunoglobulin

Cite the Article:

Aykut TS, Recep D, Munise D, Arzu A, İlkay Ö. A Case of Bupropion-Induced Toxic Epidermal Necrolysis (TEN). Ann Clin Case Rep. 2017; 2: 1396. ISSN: 2474-1655.